Rabbit polyclonal Antibody to Bevacizumab/Avastin, Polyclonal

Catalog Number: ABI-45-1112
Article Name: Rabbit polyclonal Antibody to Bevacizumab/Avastin, Polyclonal
Biozol Catalog Number: ABI-45-1112
Supplier Catalog Number: 45-1112
Alternative Catalog Number: ABI-45-1112-40UG
Manufacturer: Abeomics
Host: Rabbit
Category: Antikörper
Application: ELISA
Immunogen: Bevacizumab
Bevacizumab (Avastin) is a humanized polyclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). Anti-Bevacizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Bevacizumab.
Clonality: Polyclonal
Purity: Antigen affinity chromatography
Form: Purified
Application Dilute: ELISA detection: 0.05-0.2 ,µg/ml